Comparison of combination therapy of high-dose oral N-acetylcysteine and intravenous sodium bicarbonate hydration with individual therapies in the reduction of Contrast-induced Nephropathy during Cardiac Catheterisation and Percutaneous Coronary Intervention (CONTRAST): A multi-centre, randomised, c

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Journal of Cardiology

• Publication date

  2015-12-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijcard.2015.07.108PMID 26301645
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Female gender and contrast-induced nephropathy in primary percutaneous intervention for ST-segment elevation myocardial infarction.

  2014cited by this paper
• 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous

  2014cited by this paper
• KDOQI US commentary on the 2012 KDIGO (Kidney Disease: Improving Global Outcomes) clinical practice guideline for acute kidney injury

  2013cited by this paper
• Sodium bicarbonate for the prevention of contrast-induced nephropathy: the efficacy of high concentration solution.

  2012cited by this paper
• Notice

  2012cited by this paper
• Contemporary use and effectiveness of N-acetylcysteine in preventing contrast-induced nephropathy among patients undergoing percutaneous coronary intervention.

  2012cited by this paper
• KDIGO Clinical Practice Guidelines for Acute Kidney Injury

  2012cited by this paper
• Acetylcysteine for Prevention of Renal Outcomes in Patients Undergoing Coronary and Peripheral Vascular Angiography: Main Results From the Randomized Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT)

  2011cited by this paper
• 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

  2011cited by this paper
• 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

  2011cited by this paper
• The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST‐segment elevation acute myocardial infarction

  2011cited by this paper
• Comparison of risks and clinical predictors of contrast-induced nephropathy in patients undergoing emergency versus nonemergency percutaneous coronary interventions.

  2010cited by this paper
• Risk factors and clinical outcomes for contrast-induced nephropathy after percutaneous coronary intervention in patients with normal serum creatinine.

  2010cited by this paper
• Contrast agents and renal cell apoptosis.

  2008cited by this paper
• Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.

  2008cited by this paper
• Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial.

  2008cited by this paper
• Prevention of contrast induced nephropathy: Recommendations for the high risk patient undergoing cardiovascular procedures

  2007cited by this paper
• Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): A Randomized Comparison of 3 Preventive Strategies

  2007cited by this paper
• Contrast-Induced Nephropathy: A Clinical and Evidence-Based Approach

  2006cited by this paper
• N-acetylcysteine and contrast-induced nephropathy in primary angioplasty.

  2006cited by this paper
• What is the best hydration regimen to prevent contrast media-induced nephrotoxicity?

  2004cited by this paper
• Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial.

  2004cited by this paper
• Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity.

  2004cited by this paper
• Optimal timing of hydration to erase contrast-associated nephropathy: the OTHER CAN study.

  2003cited by this paper
• Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention

  2002cited by this paper
• Acetylcysteine and nephrotoxic effects of radiographic contrast agents--a new use for an old drug.

  2000cited by this paper
• Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.

  2000cited by this paper
• Prophylaxis against contrast-induced nephropathy.

  1999cited by this paper
• A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy ☆: Results of the P.R.I.N.C.E. study

  1999cited by this paper
• A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation.

  1999cited by this paper
• Current concepts in contrast media-induced nephropathy.

  1998cited by this paper
• N-acetyl cysteine ameliorates ischemic renal failure.

  1997cited by this paper
• Urography into the 21st century: new contrast media, renal handling, imaging characteristics, and nephrotoxicity.

  1997cited by this paper
• Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality.

  1997cited by this paper
• The effect of acute renal failure on mortality. A cohort analysis.

  1996cited by this paper
• Acute renal failure.

  1995cited by this paper
• Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents.

  1994cited by this paper
• Prevention of nephrotoxicity induced by radiocontrast agents.

  1994cited by this paper
• Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study.

  1989cited by this paper
• Hospital-acquired renal insufficiency: a prospective study.

  1983cited by this paper
• Renal failure after major angiography can be avoided with hydration.

  1981cited by this paper
• Nonoliguric acute renal failure.

  1977cited by this paper
• Guidelines on Myocardial Revascularization the Task Force on Myocardial Revascularization of the European Society of Cardiology (esc) and the European Association for Cardio-thoracic Surgery (eacts) Developed with the Special Contribution of the European Association for Percutaneous Cardiovascular I

  year unknowncited by this paper

• Preventing Contrast-Induced Acute Kidney Injury in Egyptian Patients Undergoing Coronary Angiography: A Randomized Controlled Trial.

  2026cites this paper
• The Incidence of Contrast-Induced Nephropathy Following Computed Tomography and Associated Risk Factors

  2025cites this paper
• Happiness in publishing

  2024cites this paper
• C-Reactive Protein to Albumin Ratio as a Predictor of Contrast-Induced Nephropathy After Carotid Angiography

  2022cites this paper
• CHA2DS2-VASc score as a novel predictor for contrast-induced nephropathy, irrespective to atrial fibrillation, after percutaneous coronary intervention in acute coronary syndrome

  2022cites this paper
• Contrast-induced acute renal injury: the modern state of issue

  2022cites this paper
• N-acetylcysteine in the Prevention of Contrast-induced Acute Kidney Injury: a Systematic Review and Meta-analysis of Randomized Controlled Clinical Trials

  2022cites this paper
• Contrast-induced nephropathy

  2022cites this paper
• A Novel Predictor of Contrast-Induced Nephropathy in Patients With Carotid Artery Disease; the Systemic Immune Inflammation Index

  2022cites this paper
• Health Care Analytics With Time-Invariant and Time-Variant Feature Importance to Predict Hospital-Acquired Acute Kidney Injury: Observational Longitudinal Study

  2021cites this paper
• Sodium Bicarbonate versus Statins to Prevent Contrast-induced Acute Kidney Injury: A Comprehensive Review

  2021cites this paper
• Inflammatory markers of contrast-induced nephropathy in patients with acute coronary syndrome

  2020cites this paper
• Risk Factors Associated With Contrast-Induced Nephropathy after Primary Percutaneous Coronary Intervention

  2020cites this paper
• Comparison of Oral and Intravenous N-acetyl Cysteine in Preventing Contrast Nephropathy

  2020cites this paper
• CHA2DS2-VASC SCORE AS A PREDICTOR FOR CONTRAST-INDUCED NEPHROPATHY IN PATIENT WITH ISCHEMIC HEART DISEASE TREATED WITH PERCUTANEOUS CORONARY INTERVENTION

  2020cites this paper
• Acute kidney injury: prevention, detection and management

  2019cites this paper
• Guideline on the use of iodinated contrast media in patients with kidney disease 2018

  2019cites this paper
• CHA2DS2-VASC Score Predicts Risk of Contrast-Induced Nephropathy in Non-ST Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Interventions

  2019cites this paper
• CHA2DS2-VASc score as a novel predictor for contrast-induced nephropathy after percutaneous coronary intervention in acute coronary syndrome

  2019cites this paper
• A Bayesian network meta-analysis of preventive strategies for contrast-induced nephropathy after cardiac catheterization.

  2019cites this paper
• Guideline on the use of iodinated contrast media in patients with kidney disease 2018

  2019cites this paper
• Guideline on the Use of Iodinated Contrast Media in Patients With Kidney Disease 2018.

  2019cites this paper
• The association of PRECISE-DAPT score with development of contrast-induced nephropathy in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention

  2018cites this paper
• Management and recommendations for the prevention of contrast-induced acute kidney injury: state of the art in clinical practice

  2018cites this paper
• Preventive effect of nicorandil on contrast‐induced nephropathy: a meta‐analysis of randomised controlled trials

  2018cites this paper
• The Ratio of Fibrinogen to Albumin as a Predictor of Contrast-Induced Nephropathy After Carotid Angiography

  2018cites this paper
• The Clinical Use of N-Acetylcysteine for the Treatment and Protection Against Renal Disease

  2018cites this paper
• Predictive factors for contrast-induced acute kidney injury in high-risk patients given N-acetylcysteine prophylaxis

  2018cites this paper
• Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients

  2018cites this paper
• Renal Fibrosis and Mitochondrial Damage

  2018cites this paper
• Effectiveness of contrast-associated acute kidney injury prevention methods; a systematic review and network meta-analysis

  2018cites this paper
• Predictive Value of CHA2DS2-VASC Score for Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome.

  2017cites this paper
• Strategies Preventing Contrast-Induced Nephropathy After Coronary Angiography: A Comprehensive Meta-Analysis and Systematic Review of 125 Randomized Controlled Trials

  2017cites this paper
• Reply to "Renin-angiotensin-aldosterone-system blockade and contrast-induced nephropathy".

  2016cites this paper
• Effects of combination therapy of statin and N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

  2016cites this paper
• Renin-angiotensin-aldosterone-system blockade and contrast-induced nephropathy.

  2016cites this paper
• The efficacy of N-acetylcysteine plus sodium bicarbonate in the prevention of contrast-induced nephropathy after cardiac catheterization and percutaneous coronary intervention: A meta-analysis of randomized controlled trials.

  2016cites this paper
• Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization

  2016cites this paper
• N-ацетилцистеин в профилактике контраст-индуцированного острого почечного повреждения: систематический обзор и мета-анализ рандомизированных контролируемых клинических исследований N-acetylcysteine in the Prevention of Contrast-induced Acute Kidney Injury: a Systematic Review and Meta-analysis of Ra

  year unknowncites this paper